Brain Canada and the Canadian Cancer Society (CCS) have announced the recipients of $17.9M in funding through the CCS Breakthrough Team Grants program. Each of the projects brings together researchers, health-care providers, and those affected by cancer to address gaps in cancer research. The first project—co-led by Dr Linda Carlson (University of Calgary) and Dr Ronald Shore (Queen’s University)—will study the positive role that psychedelic-assisted therapy can have for people with advanced cancer. The second project—led by a team that includes Philippe Roux (Université de Montréal), David Cook (University of Ottawa), and Jeanette Boudreau (Dalhousie University)—will focus on preventing dormancy and recurrence in ovarian cancer. The third project—co-led by Kieran Quinn (University of Toronto)—will focus on palliative care for individuals with advanced cancer.
